Ovarian cancer statistics

Cases

New cases of ovarian cancer, 2014-2016 average, UK

Deaths

Deaths from ovarian cancer, 2016, UK

Survival

Survive ovarian cancer for 10 or more years, 2010-11, England and Wales

Preventable cases

Ovarian cancer cases are preventable, UK, 2015

 

 

  • There are around 7,500 new ovarian cancer cases in the UK every year, that's 20 every day (2014-2016).
  • In females in the UK, ovarian cancer is the 6th most common cancer, with around 7,500 new cases in 2016.
  • Ovarian cancer accounts for 4% of all new cancer cases in females in the UK (2016).
  • Ovarian cancer accounts for 2% of all new cancer cases in females and males combined in the UK (2016).
  • Incidence rates for ovarian cancer in the UK are highest in females aged 75 to 79 (2014-2016).
  • Since the early 1990s, ovarian cancer incidence rates have remained stable in females in the UK.
  • Over the last decade, ovarian cancer incidence rates have decreased by around a twentieth (4%) in females in the UK.
  • Almost 6 in 10 ovarian cancer cases are diagnosed at a late stage in England (2014) and Northern Ireland (2010-2014).
  • Incidence rates for ovarian cancer are projected to rise by 15% in the UK between 2014 and 2035, to 32 cases per 100,000 females by 2035.
  • Ovarian cancer in England is not associated with deprivation.
  • Ovarian cancer is more common in White women than Asian or Black women.
  • An estimated 41,000 women who had previously been diagnosed with ovarian cancer were alive in the UK at the end of 2010.

See more in-depth ovarian cancer incidence statistics

  • There are around 4,100 ovarian cancer deaths in the UK every year, that's 11 every day (2014-2016).
  • In females in the UK, ovarian cancer is the 6th most common cause of cancer death, with around 4,200 deaths in 2016.
  • Ovarian cancer accounts for 5% of all cancer deaths in females in the UK (2016).
  • Mortality rates for ovarian cancer in the UK are highest in females aged 85 to 89 (2014-2016).
  • Since the early 1970s, ovarian cancer mortality rates have decreased by around a fifth (19%) in females in the UK.
  • Over the last decade, ovarian cancer mortality rates have decreased by a sixth (17%) in females in the UK.
  • Mortality rates for ovarian cancer are projected to fall by 37% in the UK between 2014 and 2035, to 10 deaths per 100,000 females by 2035.
  • Ovarian cancer in England is not associated with deprivation.

See more in-depth ovarian cancer mortality statistics

  • More than a third (35%) of women diagnosed with ovarian cancer in England and Wales survive their disease for ten years or more (2010-11).
  • Almost half (46%) of women diagnosed with ovarian cancer in England and Wales survive their disease for five years or more (2010-11).
  • Almost three-quarters (73%) of women diagnosed with ovarian cancer in England and Wales survive their disease for one year or more (2010-11).
  • Ovarian cancer survival in England is highest for women diagnosed aged under 40 years old (2009-2013).
  • Almost 9 in 10 women in England diagnosed with ovarian cancer aged 15-39 survive their disease for five years or more, compared with a fifth of women diagnosed aged 80 and over (2009-2013).
  • Ovarian cancer survival is improving and has almost doubled in the last 40 years in the UK.
  • In the 1970s, less than a fifth of women diagnosed with ovarian cancer survived their disease beyond ten years, now it's more than a third.
  • When diagnosed at its earliest stage, 9 in 10 women with ovarian cancer will survive their disease for five years or more, compared with less than 5 in 100 of women when diagnosed at the latest stage.
  • Five-year relative survival for ovarian cancer in women is below the European average in England, Wales, Scotland and Northern Ireland.

See more in-depth ovarian cancer survival statistics

  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 50 UK females will be diagnosed with ovarian cancer in their lifetime
  • 11% of ovarian cancer cases in the UK are preventable.

See more in-depth ovarian cancer risk statistics

  • 'Two-week wait' is the most common route to diagnosing ovarian cancer.
  • GP referral is the route with the highest proportion of cases diagnosed at an early stage, for ovarian cancer.
  • 'Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland and Wales, and ’62-day wait’ is met by all but Wales, Northern Ireland and only partly by Scotland for gynaecological cancers.
  • 64% of patients diagnosed with ovarian cancer have surgery to remove the tumour as part of their primary cancer treatment.
  • 2% of patients diagnosed with ovarian cancer have radiotherapy as part of their primary cancer treatment.
  • 54% of patients diagnosed with ovarian cancer have chemotherapy as part of their primary cancer treatment.

See more in-depth ovarian cancer diagnosis and treatment statistics

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

The latest statistics available for ovarian cancer in the UK are; incidence 2015, mortality 2016 and survival 2010-2011 (all ages combined) and 2009-2013 (by age).

The ICD codes Open a glossary item for ovarian cancer are ICD-10 C56-C57.4 which includes cancer of the ovary (C56) and other and unspecified female genital organs (C57-C57.4).

The ICD codes Open a glossary item for ovarian cancer survival are ICD-10 C56 and C57.0-C57.7.

European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.

Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages, stages Open a glossary item and co-morbidities Open a glossary item. The survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.

Meta-analyses Open a glossary item and systematic reviews Open a glossary item are cited where available, as they provide the best overview of all available research and most take study quality into account. Individual case-control and cohort studies Open a glossary item are reported where such aggregated data are lacking.

Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2012-2013. Staging proportions only include patients with a known stage (cases with an unknown stage at diagnosis are not included in the denominator).

Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Ovarian cancer is part of the group 'Gynaecological cancer' for cancer waiting times data. Codes vary per country but broadly include: Vulva, vagina, cervix, uterus, ovary, other female genital organs, placenta and secondary cancers of ovary.

Cancer surgical resection rates data is for patients diagnosed in England between 2006 and 2010.

Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.

Deprivation gradient statistics were calculated using incidence data for three time periods: 1996-2000, 2001-2005 and 2006-2010 and for mortality for two time periods: 2002-2006 and 2007-2011. The 1997-2001 mortality data were only used for the all cancers combined group as this time period includes the change in coding from ICD-9 to ICD-10. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

See also

Data sources and timings - why are these the latest statistics?

Information and explanations on terminology used for statistics

Our calculations explained

Information for patients

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 3.4 out of 5 based on 49 votes
Thank you!
We've recently made some changes to the site, tell us what you think